Roundup linked to Non-Hodgkin’s Lymphoma
Roundup is a commonly used weed killer that has been linked to lymphatic cancers. Roundup has been around since the 1970s when it was manufactured by Monsanto (acquired by Bayer in 2018), but it wasn’t until the 90s that Roundup became widely used in farms and households. Its main ingredient, glyphosate, has been in the World Health’s Organization’s list of probable carcinogens since 2015.
A study published in 2018 shows that “[there is indication of] statistically significant increased risk (41%) of NHL [Non-Hodgkin’s Lymphoma] following high cumulative GBH [glyphosate-based herbicides] exposure.”
If you have been exposed to Roundup and subsequently developed Non-Hodgkin’s Lymphoma or other lymphatic cancers, you may qualify to participate in the Roundup litigation. Contact Us today for a FREE, no-obligation consultation. Our experienced chemical exposure law team can help you assess your case and your best plan of action.
Roundup Lawsuits | What happened?
In 2018, a judge awarded $78 million to a school groundskeeper diagnosed with Non-Hodgkin’s Lymphoma after using Roundup for years. One year later, in 2019, a federal judge awarded more than $80 million in damages to another individual who had been diagnosed with Non-Hodgkin’s Lymphoma after using Roundup for 26 years in his own property.
In 2021, “[Bayer] committed $9.6 billion in June to settle around 125,000 existing claims and lawsuits by Roundup users who were already alleging the product caused their Non-Hodgkin’s Lymphoma. The company has resolved all but 30,000 of those claims.” (Reuters) Then, in July, Bloomberg reported that “[Bayer] set aside an additional $4.5 billion to deal with lawsuits tied to its best-selling Roundup weedkiller, which will be pulled from the U.S. consumer market in its current form in 2023. The provision, taken in the second quarter, comes on top of the $11.6 billion that Bayer has previously pledged to fight and settle the Roundup litigation.”
Roundup Lawsuits Eligibility | Do I have a case?
If you or a loved one has regularly been exposed to Roundup and was subsequently diagnosed with Non-Hodgkin’s Lymphoma you may qualify to participate in the Roundup litigation. Please Contact Us today for a FREE, no-obligation Roundup lawsuit consultation.
If you lost a loved one who was regularly been exposed to Roundup and subsequently developed Non-Hodgkin’s Lymphoma, Contact Us today for a FREE, no-obligation Roundup lawsuit consultation.
Roundup Lawsuits Eligibility | Eligible forms of Non-Hodgkin’s Lymphoma
According to the American Cancer Society,
“Non-Hodgkin’s Lymphoma (also known as NHL, or sometimes just lymphoma) is a cancer that starts in the white blood cells called lymphocytes, which are part of the body’s immune system.”
If you or a loved one has developed any of the following forms of Non-Hodgkin’s Lymphoma after regularly been exposed to Roundup, you should Contact Us immediately:
- Anaplastic large-cell lymphoma (ALK positive and ALK negative)
- Angioimmunoblastic T-cell lymphoma
- B-Cell Lymphoma, unspecified/ B-Cell Lymphoma, unclassifiable
- B-cell prolymphocytic leukemia (B-PLL)/Prolympocytic leukemia
- B-lymphoblastic leukemia/lymphoma NOS/B-Cell precursor lymphoma
- Blastic NK-cell lymphoma/Aggressive NK cell leukemia
- Burkitt lymphoma
- Centroblastic large-cell lymphoma
- Centrocytic lymphoma malignant lymphomatous polyposis
- Chronic lymphocytic leukemia (CLL)
- Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
- Diffuse follicle center lymphoma
- Diffuse Large B-Cell Lymphoma (DLBCL)
- EBV+ diffuse large B-cell lymphoma, NOS
- Enteropathy-type T-cell lymphoma/Intestinal T-cell lymphoma/Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL)
- Extranodal Marginal Zone BCell Lymphoma / Extranodal Marginal Zone Lymphom of mucosa associated lymphoid tissue
- Extranodal NK/T-Cell lymphoma/ Extranodal NK/T cell lymphoma, nasal type
- Follicular Lymphoma
- Gastric mucosa-associated lymphoid tissue (MALT lymphoma)
- Gray Zone Lymphoma/High Grade Lymphoma
- Hair cell leukemia (HCL)
- Hairy Cell lymphoma
- Hepatosplenic T-cell lymphoma
- Immunoblastic lymphoma
- Intravascular large B-cell lymphoma
- Large Granular Lymphocytic Leukemia/ T-cell large granular lymphocytic leukemia
- Lymphoblastic lymphoma (lymphoblastic B-cell; lymphoblastic (diffuse) lymphoma; lymphoblastic Tcell)
- Lymphoepitheliod lymphoma
- Lymphoid granulomatosis
- Lymphoplasmacytic lymphoma/ Waldenstrom macroglobulinemia
- MALT lymphoma
- Mantle cell lymphoma
- Marginal Zone lymphoma
- Mature T-cell lymphoma, not classified
- Mature T/NK-cell lymphoma, unspecified
- Mediastinal gray zone lymphoma/ B-cell lymphoma, unclassifiable, intermediate between DLBCL and class Hodgkin lymphoma
- Monocytoid B-cell lymphoma/Nodal and extranodal lymphoma
- Mycosis fungoides
- Nodal Marginal Zone B-cell lymphoma
- Non-Hodgkin lymphoma
- Peripheral T-cell lymphoma
- Plasmablastic lymphoma
- Primary Central Nervous System lymphoma/ Primary diffuse large b-cell lymphoma of the CNS/ Central Nervous System (CNS) lymphoma/ Primary intraocular lymphoma (lymphoma of the eye)
- Primary cutaneous CD30-positive T-cell lymphoma
- Primary cutaneous CD4-positive T-cell lymphoma
- Primary cutaneous diffuse large B-cell lymphoma
- Primary Cutaneous follicle center lymphoma
- Primary cutaneous peripheral T-cell lymphoma
- Primary cutaneous T-cell proliferation
- Primary effusion B-cell lymphoma
- Primary Mediastinal (thymic) large B-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Richter’s Syndrome/Transformation
- Sézary syndrome/disease
- Small B-Cell lymphoma (Small cell B-cell lymphoma)
- Small-cell lymphocytic lymphoma (SLL)
- Splenic marginal zone B-cell lymphoma
- Subcutaneous panniculitis-like T-cell lymphoma
- T-cell lymphoma, not classified/specified/peripheral T-cell lymphoma, NOS
- T-cell lymphoproliferative disorder of childhood, Epstein-Barr virus positive
- T-cell prolymphocytic leukemia (T-PLL)
- T-cell rich lymphoma/ T-cell histiocyte-rich large B-cell lymphoma
- T-lymphoblatsic leukaemia/lymphoma”/Tprecursor lymphoma
Source: Swerdlow et al, WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, World Health Organization, International Agency for Research on Cancer (2017).
Anyone who has regularly been exposed to Roundup and subsequently developed Non-Hodgkins Lymphoma, may qualify to participate in the Roundup lawsuit. If that happened to you or a loved one, Contact Us today for a FREE, no-obligation Roundup litigation consultation.
ROUNDUP LAWSUITS ELIGIBILITY
If you have been exposed to Roundup and subsequently developed Non-Hodgkin’s Lymphoma or other lymphatic cancers, you may qualify to participate in the Roundup litigation. Contact Us today for a FREE, no-obligation consultation. Our experienced chemical exposure law team can help you assess your case and your best plan of action.
Yes. Please call us or use our contact form to request a Free Case Evaluation. We have a national team of attorneys and staff who look forward to speaking with you.
Typically, we represent clients on contingency fee agreements. If we take your case under a contingency fee arrangement, you won’t owe our firm any legal fees unless we are able to recover money for you.
Our contingency fee agreements are usually based on a percentage of the amount we recover for our clients. The contingency fee amount is determined by the type of case, our estimate of how long it will take to resolve your case, and our estimate of the litigation costs we will advance in your case. Each engagement agreement includes the details of the fee arrangement. Questions about our fee agreements are welcomed and encouraged.
In most litigation matters, it is extremely difficult – practically impossible – to predict how long it will take to resolve a particular case. Every case is different, and we will do our best to provide you with an estimate based on your case and our experience with similar cases. Moreover, we will do our best to keep you updated and manage expectations along the way.
We handle cases that change lives. Contact us today for a FREE consultation.
